110 related articles for article (PubMed ID: 33403356)
1. EHA Endorsement of ESMO Clinical Practice Guidelines for Diagnosis, Treatment, and Follow-up of Chronic Lymphocytic Leukemia.
Eichhorst B; Ghia P
Hemasphere; 2021 Jan; 5(1):e520. PubMed ID: 33403356
[No Abstract] [Full Text] [Related]
2. EHA Endorsement of ESMO Clinical Practice Guidelines for Diagnosis, Treatment, and Follow-up for Myelodysplastic Syndromes.
van de Loosdrecht AA; Mandac Smoljanović I
Hemasphere; 2022 Mar; 6(3):e695. PubMed ID: 35233507
[No Abstract] [Full Text] [Related]
3. EHA Endorsement of ESMO Clinical Practice Guidelines for Diagnosis, Treatment, and Follow-up for Waldenström's Macroglobulinemia.
Staber PB; Kersten MJ
Hemasphere; 2021 Oct; 5(10):e634. PubMed ID: 34522842
[No Abstract] [Full Text] [Related]
4. EHA Endorsement of ESMO Clinical Practice Guidelines for Marginal Zone Lymphomas.
Ladetto M; Dreyling M
Hemasphere; 2020 Apr; 4(2):e351. PubMed ID: 32309788
[No Abstract] [Full Text] [Related]
5. EHA Endorsement of ESMO Clinical Practice Guidelines for Newly Diagnosed and Relapsed Follicular Lymphoma.
Ladetto M; Dreyling M
Hemasphere; 2021 May; 5(5):e559. PubMed ID: 33898930
[No Abstract] [Full Text] [Related]
6. EHA Endorsement of ESMO Clinical Practice Guidelines for Newly Diagnosed and Relapsed Mantle Cell Lymphoma.
Linton K; Dreyling M
Hemasphere; 2020 Oct; 4(5):e464. PubMed ID: 32885149
[No Abstract] [Full Text] [Related]
7. Chronic lymphocytic leukemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Eichhorst B; Dreyling M; Robak T; Montserrat E; Hallek M;
Ann Oncol; 2011 Sep; 22 Suppl 6():vi50-4. PubMed ID: 21908504
[No Abstract] [Full Text] [Related]
8. Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up.
Dimopoulos MA; Moreau P; Terpos E; Mateos MV; Zweegman S; Cook G; Delforge M; Hájek R; Schjesvold F; Cavo M; Goldschmidt H; Facon T; Einsele H; Boccadoro M; San-Miguel J; Sonneveld P; Mey U
Hemasphere; 2021 Feb; 5(2):e528. PubMed ID: 33554050
[No Abstract] [Full Text] [Related]
9. Correction Notice: Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up.
Hemasphere; 2021 Dec; 5(12):e659. PubMed ID: 34859196
[TBL] [Abstract][Full Text] [Related]
10. Correction Notice: Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up.
Hemasphere; 2021 Apr; 5(4):e567. PubMed ID: 33824948
[TBL] [Abstract][Full Text] [Related]
11. Primary central nervous system lymphomas: EHA-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Ferreri AJM; Illerhaus G; Doorduijn JK; Auer DP; Bromberg JEC; Calimeri T; Cwynarski K; Fox CP; Hoang-Xuan K; Malaise D; Ponzoni M; Schorb E; Soussain C; Specht L; Zucca E; Buske C; Jerkeman M; Dreyling M;
Hemasphere; 2024 Jun; 8(6):e89. PubMed ID: 38836097
[TBL] [Abstract][Full Text] [Related]
12. Corrigendum to 'Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up': [Ann Oncol 2021; 32(3): 309-322].
Dimopoulos MA; Moreau P; Terpos E; Mateos MV; Zweegman S; Cook G; Delforge M; Hájek R; Schjesvold F; Cavo M; Goldschmidt H; Facon T; Einsele H; Boccadoro M; San-Miguel J; Sonneveld P; Mey U;
Ann Oncol; 2022 Jan; 33(1):117. PubMed ID: 34857439
[No Abstract] [Full Text] [Related]
13. Corrigendum to "Corrigendum to 'Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up'": [Ann Oncol Volume 33, Issue 1, January 2022, Page 117].
Dimopoulos MA; Moreau P; Terpos E; Mateos MV; Zweegman S; Cook G; Delforge M; Hájek R; Schjesvold F; Cavo M; Goldschmidt H; Facon T; Einsele H; Boccadoro M; San-Miguel J; Sonneveld P; Mey U;
Ann Oncol; 2022 Sep; 33(9):988. PubMed ID: 35810138
[No Abstract] [Full Text] [Related]
14. Chronic lymphocytic leukemia: ESMO minimum clinical recommendations for diagnosis, treatment and follow-up.
Eichhorst B; Hallek M; Dreyling M;
Ann Oncol; 2009 May; 20 Suppl 4():102-4. PubMed ID: 19454423
[No Abstract] [Full Text] [Related]
15. Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Eichhorst B; Hallek M; Dreyling M;
Ann Oncol; 2010 May; 21 Suppl 5():v162-4. PubMed ID: 20555070
[No Abstract] [Full Text] [Related]
16. Chronic lymphocytic leukemia: ESMO clinical recommendations for diagnosis, treatment and follow-up.
Eichhorst B; Hallek M; Dreyling M;
Ann Oncol; 2008 May; 19 Suppl 2():ii60-2. PubMed ID: 18456771
[No Abstract] [Full Text] [Related]
17. Chronic lymphocytic leukemia: ESMO clinical recommendations for diagnosis, treatment and follow-up.
; Hallek M
Ann Oncol; 2007 Apr; 18 Suppl 2():ii49-50. PubMed ID: 17491044
[No Abstract] [Full Text] [Related]
18. EHA/ESMO Clinical Practice Guidelines for the Management of Malignant Lymphoma: Recommendations for the Second Phase of the COVID-19 Pandemic.
Dreyling M; Aurer I; Federico M; Jerkeman M; Kersten MJ; Linton K; Mey U; Tilly H; Buske C
Hemasphere; 2021 Feb; 5(2):e529. PubMed ID: 33880434
[No Abstract] [Full Text] [Related]
19. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of chronic lymphocytic leukemia.
Hallek M; Stahel RA; Greil R;
Ann Oncol; 2005; 16 Suppl 1():i50-1. PubMed ID: 15888753
[No Abstract] [Full Text] [Related]
20. Chronic myeloid leukemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Baccarani M; Pileri S; Steegmann JL; Muller M; Soverini S; Dreyling M;
Ann Oncol; 2012 Oct; 23 Suppl 7():vii72-7. PubMed ID: 22997458
[No Abstract] [Full Text] [Related]
[Next] [New Search]
